# Step 184 — PC07.10 formal qualified closure and inventory reconciliation

2026-10-25 (America/Toronto). **PC07.10 — SATISFIED — VERIFIED WITH QUALIFICATIONS. Owner disposition: APPROVED. Formal internal requirement closure recorded. Mandatory-gap inventory: 8 → 7 distinct IDs; 3 → 3 nonempty packages.** All clinician/release and deferred runtime/manual qualifications remain in their recorded scopes. Requirement closure does not constitute clinician sign-off, unconditional release readiness or external OntarioMD/CPSO acceptance. Documentation only; no implementation or verification repeated.

## 1. Explicit owner disposition

The Step 184 owner instruction explicitly approves formal closure of **PC07.10** as **SATISFIED — VERIFIED WITH QUALIFICATIONS**, requires preservation of the documented qualifications, and authorizes removal of only PC07.10 from the mandatory-gap inventory.

**Disposition: APPROVED and recorded on 2026-10-25.** This resolves the owner-decision gate left open by [Step 183](259-step183-pc07-10-evidence-reconciliation.md), sections 5–7. No approval of an unexecuted test, clinical policy, product release, account/permission change or additional runtime action is inferred.

This report is the new current PC07.10 status and mandatory-gap inventory entry in the existing **append-only per-step Markdown inventory**. It supersedes Step 183's pending-approval status and eight-ID inventory for the present checkpoint. Step 183 and earlier reports remain unchanged as historical evidence; no separate tracker is invented or unrelated status document rewritten.

## 2. Requirement coverage and retained evidence

The recovered mandatory requirement and scope are retained from [Step 183 sections 1–3](259-step183-pc07-10-evidence-reconciliation.md), which links the authoritative Step 174 recovery: ability to record/update all CPP categories, with at least **Diagnosis, Procedures and Medication Summary managed from SOAP/Progress encounters**.

The evidence matrix accounts for all eight category mechanisms: ongoing conditions; past Medical/Surgical History; Family History; immunizations; allergies/adverse reactions; Medication Summary; Risk Factors; medical alerts/special needs. It also accounts for all three encounter paths. This closure concerns those mechanisms and encounter capabilities; it does not declare every independent PC07.01 dictionary/source/authority residual resolved.

| Evidence | Accepted outcome / reference |
|---|---|
| Procedure automated verification | **142 distinct final .NET PASS** in [Step 176 section 5](248-step176-pc07-10-procedure-foundation-implementation.md), retained by Step 183 section 4: 26 new focused + 116 affected final outcomes, plus separately reported frontend evidence. |
| Medication automated verification | **56 distinct final .NET PASS** in [Step 177 section 6](249-step177-pc07-10-encounter-medication-implementation.md), retained by Step 183 section 4: 29 new + 27 affected, plus separately reported frontend evidence. |
| Category and Diagnosis evidence | [Step 183 section 3](259-step183-pc07-10-evidence-reconciliation.md) retains the exact category report/test/owner-acceptance mapping and [Step 70](104-step70-pc08-06-evidence-reconciliation-next-gap.md)'s 27 focused Diagnosis cases and qualified owner acceptance. No new Diagnosis save or whole-category test campaign is claimed. |
| SQL capability and deployment prerequisites | [Step 179D](254-step179d-pc07-10-permission-discrepancy-investigation.md) verifies the five effective permissions for microemr_dev and reconciles catalog normalization; accepted applied 0092 and bounded deployment provenance are retained through Steps 183/182B. No fresh environment or SQL assessment occurred here. |
| Deployed positive acceptance | [Step 182B sections 2–9](258-step182b-pc07-10-deployed-clinical-acceptance.md): **one successful authenticated session and five verified clinical saves** in the approved development tenant. Procedure create/update and Medication create/update/discontinue used normal Web workflows; existing medication selection was read-only. |
| Integrity and source synchronization | Step 182B correlates trusted actor 2, expected patient/encounter/source, **five mutation audits and five provenance rows**, source RowVersion advances and fresh CPP projections. Signed panels were read-only. No unintended clinical changes were observed within the documented comparison scope. |
| Prescription/artifact protection | Step 182B verifies both existing prescription rows and full artifact content/identity/hash unchanged throughout. No prescription modification or artifact operation was needed to perform the five saves. |

**Do not sum overlapping automated counts.** The 142 and 56 totals are retained within their original per-step scopes; shared regressions and historical runs are not a new deduplicated combined total. Frontend groups, deployed saves and read-audit observations are not additional .NET cases. No tests or acceptance scenarios were rerun in Step 184.

Step 182B's accepted local receipt `.tmp/step182b/acceptance-summary.json` has SHA-256 **28C2B73CE2A819F9E3917339C4EA68D68D2666916E8B6F622C632DFF10EAC7C0**. Its report preserves the baseline/final/browser receipt hashes, source identities, audit IDs, versions and captures. Step 184 reuses that evidence, without a new live-state attestation.

## 3. Qualification ledger — carried forward without waiver

The following substantive rows are copied **verbatim from Step 183 section 5**, preserving classification, scope and closure limitations. Their original evidence references are retained through [Step 183's matrix/ledger](259-step183-pc07-10-evidence-reconciliation.md), with the controlling reports linked in section 2 above. They remain applicable after formal internal qualified closure. Wording about a qualified recommendation describes the evidence boundary accepted by the owner; it does not upgrade any unexecuted scenario to PASS.

| Item | Classification | Evidence / remaining boundary | Does it prevent closure? |
|---|---|---|---|
| Mandatory all-category record/update capability and three encounter paths | **SATISFIED** | Sections 3–4 account for the mechanisms and accepted evidence; original two integrations now implemented/positively accepted. | No demonstrated functional blocker remains for the recovered PC07.10 scope. |
| Clinician workflow/semantic review | **DEFERRED** | No clinician sign-off for neutral Procedure semantics, structured Progress interpretation or complete workflow usability was recorded. Owner engineering approval/technical PASS is not clinical approval. | Prevents claiming clinician approval or unconditional clinical acceptance. Not an additional explicit PC07.10 capability gap; must be carried into any internal qualified closure. A later clinical finding could require reassessment. |
| Certification release/source applicability | **QUALIFIED** | Baseline folder 5.5 vs document 1.7 and referenced CDS-S folder/workbook/target-release distinctions remain; technical tests do not establish external acceptance. | Prevents unconditional target-release/OntarioMD/CPSO acceptance. Internal qualified closure is supportable only with this explicit limit; no source applicability decision is invented. |
| Deferred Diagnosis authorization/security runtime scenarios | **DEFERRED** | Step 70 expressly preserves restricted-role, other-patient/encounter, two registered tenant and associated audit observations. Its owner-authorized cross-tenant deferral remains. | No newly demonstrated functional defect; retain this named security evidence lane. It blocks a claim that those deployed scenarios passed, not automatically the bounded qualified functionality decision. |
| New Procedure/Medication authorization and trusted actor | **QUALIFIED** | Steps 176/177 isolated gates cover denied permissions, spoofed/inactive actor and source/state checks; Step 182B verifies positive actor 2/session scope. No new restricted-account mutation probe. | No missing implementation demonstrated; no whole live permission-matrix PASS. Additional live negative evidence requires a separately selected/authorized scope if the reviewer requires it. |
| Tenant/patient isolation | **QUALIFIED** | Relevant two-store foreign-ID/both-direction isolated tests plus selected-tenant owned positive deployment evidence. Family's two-session successes are not transferred to these paths. | Sufficient scoped safeguard evidence for a qualified recommendation; not proof of every registered-tenant HTTP permutation. Full deployed adversarial acceptance remains deferred. |
| Clinical audit completeness/atomicity for affected saves | **SATISFIED** | Five source audits plus five correct provenance rows, actor/patient/source payload correlation and no duplicates; isolated domain/late-provenance fault rollback tests. | No observed audit defect blocks these workflows. Deployment fault-injection was not performed and no domain-wide completeness claim is made. |
| RowVersion, signing and retained records | **QUALIFIED** | Successful source advances/stable encounter tokens; Signed UI read-only; isolated stale-source/context, archived/terminal and signing-lock order tests. | No demonstrated blocker. Full deployed concurrent signing/replay/stale-failure scenarios remain unexecuted; positive acceptance does not replace them. |
| Persisted note preservation / transient unsaved drafts | **QUALIFIED** | Persisted notes/structured JSON unchanged in deployed snapshots; compiled-module tests cover independent unsaved input; transient draft preservation was not exercised in real Chromium. | Not a new mandatory clause or proven defect; retain the precise deployment observation gap. If adopted as a required final manual scenario, separately scope it before claiming completion. |
| Deployed legacy Surgical update | **DEFERRED** | Genuine legacy upgrade/update/applicability preservation tested in isolated SQL; no live Surgical fixture or extra save was added. | No missing capability shown and no extra fixture is inherently mandated by PC07.10. Cannot claim that specific deployed mutation was observed. |
| Focused UI/accessibility observations | **QUALIFIED** | Step 182B Open/Signed desktop/mobile, associated labels, two keyboard transitions, polite status messages and scrolling observations. | Supports bounded presentation; comprehensive assistive-technology/physical-device or WCAG acceptance remains outside this evidence. |
| Parent PC07.01 fields/source/authority and native wording decisions | **QUALIFIED** | Retained parent tracker and Step 156 pending decisions are not closed by new encounter management. | Preserve PC07.01 PARTIAL and its independent inventory entry. Do not relabel these as missing PC07.10 encounter panels or silently resolve them. |

For precise reference resolution, the retained Diagnosis deferral is in [Step 70 sections E–F](104-step70-pc08-06-evidence-reconciliation-next-gap.md); new Procedure/Medication safeguards and their isolated/deployed limits are in [Step 176 sections 4–6](248-step176-pc07-10-procedure-foundation-implementation.md), [Step 177 sections 4–6](249-step177-pc07-10-encounter-medication-implementation.md) and [Step 182B sections 6–8](258-step182b-pc07-10-deployed-clinical-acceptance.md). Parent native wording/source/authority qualifications retain the [Step 156](223-step156-pc07-01-owner-acceptance-and-evidence-consolidation.md) and Step 183 references. No Family-specific security success is transferred to these paths.

**The only ledger transition is the owner-approval gate.** Step 183 recorded “Formal owner approval of PC07.10 closure” as **BLOCKED — awaiting decision** and explicitly stated that it prevented inventory removal in that step. The present explicit owner disposition resolves that governance gate to **SATISFIED — APPROVED**. All substantive rows above retain their original dispositions. No clinician/release/security qualification was waived, closed, downgraded or represented as executed by that approval.

**Release-readiness distinction:** clinician workflow/semantic review and certification release/source applicability remain outstanding release obligations in their original DEFERRED/QUALIFIED scopes, including the Baseline folder/document and CDS-S target-release distinctions. Focused accessibility observations are not complete assistive-technology/WCAG acceptance. General release/production readiness, restore readiness or external certification is not established by formal PC07.10 functional closure. The owner approval is a decision on this qualified internal requirement disposition only.

Step 182B's other explicit limitations are retained: positive saves were Procedure in SOAP and Medication in structured context, with both panels initialized in both; not every action was repeated in every editor; a Form template label is not independent clinical Progress semantics approval. No new live Surgical mutation, transient unsaved-draft scenario, stale/replay/signing-race/permission-denial/cross-tenant mutation or deployed fault injection occurred. Nine automatic CDS-evaluate POSTs were guard-blocked outside that acceptance scope; no CDS behavior is certified. Its explained helper loading/fieldset/EndDate comparisons do not establish additional clinical writes or unresolved product failures. These are retained boundaries, not new mandatory-gap IDs or new passed scenarios.

If an applicable release/reviewer later requires a deferred assertion or identifies a requirement-specific defect, record that finding and assess its effect in a separately scoped step. Qualified closure does not erase the evidence register or pre-approve future runtime actions.

## 4. Formal closure rationale

The [Step 183 reconciliation](259-step183-pc07-10-evidence-reconciliation.md) establishes the exact requirement, category/Diagnosis coverage, completion of the two previously missing encounter integrations, focused safeguards and successful deployed positive acceptance. No remaining mandatory functional omission or unexplained authentication, SQL-permission, source/audit/version, CPP synchronization or prescription-integrity failure was demonstrated in that reviewed scope.

The explicit owner approval now supplies the final governance decision previously missing. **PC07.10 is therefore formally closed internally as SATISFIED — VERIFIED WITH QUALIFICATIONS.** It is removed from the unresolved mandatory-gap count while the substantive qualification ledger remains open as recorded. This closes neither PC07.01 nor any prescribing/scheduling requirement and does not assert unconditional clinical/release/external approval.

## 5. Authoritative inventory reconciliation

Before writing this closure, [Step 183 section 7](259-step183-pc07-10-evidence-reconciliation.md) was checked as the current append-only inventory checkpoint. Its eight distinct identifiers are exactly **PC04.01, PC04.06, PC04.07, PC04.09, PC04.14, PC07.01, PC07.10, PC09.03**, grouped **5 + 2 + 1** across Prescribing, CPP and Scheduling. This matches the owner-stated baseline; no discrepancy was found and no count was forced.

| Package | Before: unresolved mandatory IDs | Closed here | After: unresolved mandatory IDs | Count before → after |
|---|---|---|---|---:|
| Prescribing | PC04.01, PC04.06, PC04.07, PC04.09, PC04.14 | None | PC04.01, PC04.06, PC04.07, PC04.09, PC04.14 | **5 → 5** |
| CPP | PC07.01, PC07.10 | **PC07.10** | PC07.01 | **2 → 1** |
| Scheduling | PC09.03 | None | PC09.03 | **1 → 1** |
| **Total distinct IDs** | **8** | **1** | **7** | **8 → 7** |
| **Nonempty packages** | **3** | **0 packages removed** | **3** | **3 → 3** |

**Current unresolved mandatory inventory: 7 IDs / 3 packages**, recalculated as **5 + 1 + 1 = 7**. All three packages remain nonempty. PC07.10's qualifications remain outside this functional-gap count in section 3, rather than being lost or promoted into additional top-level IDs.

| Remaining ID | Status/evidence disposition in Step 184 |
|---|---|
| PC04.01 | Unchanged; retain its existing prescribing evidence and unresolved status. |
| PC04.06 | Unchanged; retain its existing prescribing evidence and unresolved status. |
| PC04.07 | Unchanged; retain its existing prescribing evidence and unresolved status. |
| PC04.09 | Unchanged; retain its existing prescribing evidence and unresolved status. |
| PC04.14 | Unchanged; retain its existing prescribing evidence and unresolved status. |
| PC07.01 | **PARTIAL**, unchanged; full dictionary/source/authority residuals and native wording qualifications remain independent of this closure. |
| PC09.03 | Unchanged; retain its existing scheduling evidence and unresolved status. |

No unrelated requirement is reassessed or relabelled. Previously accepted qualified PC07.04/PC07.07 and subordinate DE08.008 closures remain intact. The historical Step 183 pending-approval row and eight-ID table are preserved; this section is the current approved status/inventory entry, following the established [Step 173 append-only convention](245-step173-pc07-04-evidence-closure-inventory.md).

## 6. Proposed Step 185

**Step 185 — remaining seven-ID mandatory-gap prioritization and next bounded scope.** Reuse the existing residual/evidence records for the five Prescribing IDs, PC07.01 and PC09.03; identify current owner/supplier/clinical decisions and select one next actionable gap without reopening completed PC07.10 tests or acceptance. Carry the PC07.10 clinician/release/deferred-runtime ledger separately. Propose the smallest evidence or implementation step and its explicit authorization boundary; do not begin product work, clinical actions or new verification automatically.

## 7. Files, documentary checks and stop

Only **260-step184-pc07-10-qualified-closure.md** was created outside ignored `.tmp/step184/` documentary-check receipts. No historical evidence/status report was edited. Checks: exact eight-ID baseline against Step 183; only-PC07.10 removal; seven-ID uniqueness and **5 + 1 + 1** / three-package arithmetic; substantive ledger text preservation; report links, UTF-8/whitespace and controlling report preservation hashes. These are documentation checks, not product tests or newly executed acceptance.

No application source edit, SQL access/change, clinical write, login/browser test, build/automated test, migration/deployment/restart, branch operation, commit/push/merge/reset/clean/stash, Git command or GitHub operation occurred. Existing manual/uncommitted work was preserved. Stop after documentation and inventory reconciliation.
